Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection
Preoperative PNI affected adjuvant chemotherapy continuation and related adverse events in patients who underwent neoadjuvant chemotherapy and curative resection. Additional perioperative anti-inflammatory management and nutritional support may be required to improve the clinical course of postoperative adjuvant chemotherapy and patient survival.
Authors
- Satoshi Kobayashi (ORCID: https://orcid.org/0000-0002-7760-0771)
- Toru Aoyama
- Naoto Yamamoto (ORCID: https://orcid.org/0000-0003-0613-5451)
- Daishi Takahashi
- Soichiro Morinaga (ORCID: https://orcid.org/0009-0001-1551-1837)
- Yukio Maezawa
- ITARU HASHIMOTO (ORCID: https://orcid.org/0000-0002-8398-1494)
- Yuto Kamioka
- Makoto Ueno (ORCID: https://orcid.org/0000-0003-4480-0029)
- Yasushi Rino (ORCID: https://orcid.org/0000-0002-6858-3420)
- Masaaki Murakawa
- Rei Kanemoto
- Takashi Oshima (ORCID: https://orcid.org/0000-0003-3349-2649)
- Shinnosuke Kawahara
- Norio Yukawa
- Aya Saito
Institutions
- Kanagawa Prefectural Hospital Organization (JP)
- Kanagawa Cancer Center
- Yokohama City University (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1186/s12885-024-13244-z
- Citations
- 7
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.98